TY  - JOUR
T1  - B-vitamin therapy for diabetic nephropathy
AU  - Kadam S, Kulshrestha S, Swaminathan S
Y1  - 2010/08/11
N1  - 10.1001/jama.2010.1105
JO  - JAMA
SP  - 636
EP  - 637
VL  - 304
IS  - 6
N2  - 
Second, inclusion criteria for this study were any diabetic patient with albuminuria greater than 300 mg per day and stage 2 or 3 chronic kidney disease. Rate of progression of chronic kidney disease is more rapid in stage 3 compared with stage 2,2- 5 so effects of B-vitamin supplementation could be different in the 2 subgroups. We would like to see the hazard ratios stratified by chronic kidney disease stage at baseline.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2010.1105
UR  - http://dx.doi.org/10.1001/jama.2010.1105
ER  -